期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

全髋关节置换术后联合抗骨质疏松治疗的价值 被引量：8

原文传递
导出
摘要 随着我国步入老龄化社会，预计到2020年，我国骨质疏松患者将增至2．866亿人，骨质疏松性髋部骨折人数将达163．82万；到2050年全球骨质疏松症患者人数可达到5．333亿，全球一半以上骨质疏松性髋部骨折将发生在亚洲，每年可能会有超过300万例髋部骨折病例；在所有髋部骨折患者中，估计17％-21％的病人在2年内将经历另一次某种类型的骨折。由此可见，临床上骨质疏松症所引起的髋部骨折及二次骨折发病率很高，严重影响患者生活质量，
作者 袁宏 钟惠琴 陆琳松 哈巴西.卡肯 赵巍 殷剑 肖伟 徐阔
机构地区 新疆维吾尔自治区人民医院关节外科
出处 《中华关节外科杂志（电子版）》 CAS 2014年第3期76-78,共3页 Chinese Journal of Joint Surgery(Electronic Edition)
关键词 全髋关节置换术 抗骨质疏松 后联合 骨质疏松患者 髋部骨折 骨质疏松性 骨质疏松症 价值
分类号 R687.4 [医药卫生—骨科学]
  • 相关文献

参考文献3

二级参考文献25

  • 1陈东旭,刘志欣,张立波,董世艳.鳗鱼降钙素对老年性骨质疏松症骨密度和骨转换指标的影响[J].华北煤炭医学院学报,2006,8(1):39-40. 被引量：3
  • 2Corrado A, Neve A, Maruotti N, et al. Dose-dependent metabolic effect of zol.edronate on primary human osteoblastic cell cultures[J]. Clin Exp Rheumatol, 2010, 28(6):873-879.
  • 3Mori GG, Janjacomo DM, Nunes DC, et al. Effect of zoledronic acid used in the root surface treatment of late replanted teeth: a study in rats[J]. Braz Dent J,2010,21(5): 452-457.
  • 4Leal T, Tevaarwerk A, Love R, et al. Randomized trial of adjuvant zoledronic acid in postmenopausal women with high risk breast cancer[J]. Clin Breast Cancer, 2010, 10(6): 471- 476.
  • 5Hamdy RC. Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass[J]. Drug Des Devel Ther, 2010,4: 321-335.
  • 6Goeree R, Blaekhouse G, Adaehi J. Cost-effectiveness of alternative treatments (or women with osteoporosis in Canada [J]. Curr Med Res Opin, 2006,22(7): 1425-1436.
  • 7Goeree R, Blackhouse G, Adachi J. Cost-effectiveness of alternative treatments for women with osteoporosis in Canada [J]. CurrMedRes Opin, 2006,22(7): 1425-1436.
  • 8Muguruma H, Yano S, Kakiuchi S, et al. Reveromycin A inhibits osteolytie bone metastasis of small cell lung cancer cells, SBC-5, through an antiosteoclastic activity [ J ]. Clin Cancer Res, 2005,11(24 Pt 1):8822-8828.
  • 9Canalis E. Mechanisms of glucocorticoid action in bone [J]. Curr Osteoporos Rep,2005,3 (3):98-102.
  • 10Vestergaard P, Re inmark L, Mosekilde L. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures[J]. Calcif Tissue Int,2008,82(4) :249-257.

共引文献130

同被引文献87

  • 1王溪原,张伟,冯晰民.绝经女性被动吸烟行为对骨密度指标及抗骨折能力影响的调查[J].实用预防医学,2007,14(2):335-337. 被引量：9
  • 2李玲,余丽芳,刘志刚.CT扫描在全髋关节置换术后骨盆骨溶解诊断中的应用价值研究与护理分析[J].环球中医药,2013,(Z1):306-307.
  • 3Ford MA, Bass M, Zhao Y, et al. Osteoporosis Knowledge, Self-Efficacy, and Beliefs among College Students in the USA and China. J Osteoporos. 2011; 2011:729219.
  • 4Balasubramanian A, Tosi LL, Lane JM, et al. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009. J Bone Joint Surg Am. 2014;96(7):e52.
  • 5Cosman F, de Beur S J, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381.
  • 6Wang E, Yi H, Wang M, et al. Treatment of osteoporotic vertebral compression fractures with percutaneous kyphoplasty: a report of 196 cases. Eur J Orthop Surg Traumatol. 2013;23 Suppl 1 :$71-75.
  • 7Klazen CA, Venmans A, de Vries J, et al. Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures: results from VERTOS I1. AJNR Am J Neuroradiol. 2010;31(8): 1447-1450.
  • 8Lu K, Liang CL, Hsieh CH, et all Risk factors of subsequent vertebral compression fractures after vertebroplasty. Pain Med. 2012; 13(3):376-382.
  • 9Yoo CM, Park KB, Hwang SH, et al. The analysis of patterns and risk factors of newly developed vertebra compression fractures after percutaneous vertebroplasty. J Korean Neurosurg Soc. 2012; 52(4) 339-345.
  • 10Lin WC, Lee YC, Lee CH, et al. Refractures in cemented vertebrae after percutaneous vertebroplasty: a retrospective analysis. Eur Spine J. 2008; 17(4):592-599.

引证文献8

二级引证文献74

中华关节外科杂志（电子版）
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部